EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Enhanced Endosomal Signaling and Desensitization of GLP-1R vs GIPR in Pancreatic Beta Cells

Yusman Manchanda, Stavroula Bitsi, Shiqian Chen, Johannes Broichhagen, Jorge Bernardino de la Serna, Ben Jones iD, Alejandra Tomas iD

Endocrinology · 2023

DOI: 10.1210/endocr/bqad028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrinology, 2023. Verfasst von Yusman Manchanda und 6 weiteren Autor:innen. Beteiligte Einrichtung: Section of Cell Biology and Functional Genomics, Department of Metabolism, Digestion and Reproduction, Imperial College London, London W12 0NN, UK. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Insulin-Secreting Cells, Receptors, Gastrointestinal Hormone. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The incretin receptors, glucagon-like peptide-1 receptor (GLP-1R) and glucose-dependent insulinotropic polypeptide receptor (GIPR), are prime therapeutic targets for the treatment of type 2 diabetes (T2D) and obesity. They are expressed in pancreatic beta cells where they potentiate insulin release in response to food intake. Despite GIP being the main incretin in healthy individuals, GLP-1R has been favored as a therapeutic target due to blunted GIPR responses in T2D patients and conflicting effects of GIPR agonists and antagonists in improving glucose tolerance and preventing weight gain. There is, however, a recently renewed interest in GIPR biology, following the realization that GIPR responses can be restored after an initial period of blood glucose normalization and the recent development of dual GLP-1R/GIPR agonists with superior capacity for controlling blood glucose levels and weight. The importance of GLP-1R trafficking and subcellular signaling in the control of receptor outputs is well established, but little is known about the pattern of spatiotemporal signaling from the GIPR in beta cells. Here, we have directly compared surface expression, trafficking, and signaling characteristics of both incretin receptors in pancreatic beta cells to identify potential differences that might underlie distinct pharmacological responses associated with each receptor. Our results indicate increased cell surface levels, internalization, degradation, and endosomal vs plasma membrane activity for the GLP-1R, while the GIPR is instead associated with increased plasma membrane recycling, reduced desensitization, and enhanced downstream signal amplification. These differences might have potential implications for the capacity of each incretin receptor to control beta cell function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Insulin-Secreting CellsReceptors, Gastrointestinal HormoneHumansBlood GlucoseGastric Inhibitory PolypeptideIncretinsGlucagon-Like Peptide-1 Receptor AgonistsGlucagon-Like Peptide-1 Receptor

Stichwörter der Autor:innen

GIPRGLP-1Rbeta cellincretinsignal compartmentalizationtrafficking

Substanzen

Blood GlucoseGastric Inhibitory PolypeptideIncretinsReceptors, Gastrointestinal HormoneGlucagon-Like Peptide-1 Receptor Agonistsgastric inhibitory polypeptide receptorGLP1R protein, humanGlucagon-Like Peptide-1 Receptor

Autor:innen und Institutionen

  • Section of Cell Biology and Functional Genomics, Department of Metabolism, Digestion and Reproduction, Imperial College London, London W12 0NN, UK.
  • Section of Endocrinology and Investigative Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, London W12 0NN, UK.
  • Chemical Biology, Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin 13125, Germany.
  • National Heart and Lung Institute, Imperial College London, London W12 0NN, UK.

ORCID-Profile: Ben Jones, Alejandra Tomas

Förderung

  • Medical Research Council

Zitieren

APA

Manchanda, Y., Bitsi, S., Chen, S., Broichhagen, J., Bernardino de la Serna, J., Jones, B., & Tomas, A. (2023). Enhanced Endosomal Signaling and Desensitization of GLP-1R vs GIPR in Pancreatic Beta Cells. Endocrinology. https://doi.org/10.1210/endocr/bqad028

Vancouver

Manchanda Y, Bitsi S, Chen S, Broichhagen J, Bernardino de la Serna J, Jones B, et al. Enhanced Endosomal Signaling and Desensitization of GLP-1R vs GIPR in Pancreatic Beta Cells. Endocrinology. 2023. doi:10.1210/endocr/bqad028

BibTeX
@article{Manchanda2023,
  author = {Manchanda, Yusman and Bitsi, Stavroula and Chen, Shiqian and Broichhagen, Johannes and Bernardino de la Serna, Jorge and Jones, Ben and Tomas, Alejandra},
  title = {Enhanced Endosomal Signaling and Desensitization of GLP-1R vs GIPR in Pancreatic Beta Cells},
  journal = {Endocrinology},
  year = {2023},
  doi = {10.1210/endocr/bqad028}
}
Kostenlos starten →